As researchers continue to study the ways GLP-1 receptor agonists influence sleep, there is growing optimism that these medications could reshape the treatment landscape for OSA and beyond
Journal of Clinical Medicine, 11(3), 5915
These figures should be interpreted in the context of a controlled trial population
Employers surveyed by KFF reported that utilization came in higher than expected and that adding coverage significantly increased prescription drug spending, and many said they were weighing whether to scale coverage back
1 The World Health Organization has estimated that in 2021, higher-than-optimal body mass index (BMI) caused an estimated 3.7 million deaths from noncommunicable diseases such as cardiovascular diseases, diabetes, cancers, neurological disorders, chronic respiratory diseases, and digestive disorders